NYSE:PBHPharmaceuticals
Prestige Consumer Healthcare (PBH) Is Up 5.6% After Raising Fiscal 2027 Outlook on Acquisitions
In early August 2026, Prestige Consumer Healthcare reported fiscal 2027 first‑quarter results showing revenue of US$265.71 million, up from US$249.53 million a year earlier, while net income fell to US$29.18 million and diluted EPS from continuing operations declined to US$0.61.
Following these results, the company raised its fiscal 2027 outlook, lifting expected revenue to US$1.29 billion–US$1.32 billion and guiding GAAP diluted EPS to US$4.18–US$4.28, largely reflecting the addition of...